RKDANasdaq United States
Market cap
$1.677 M
$0.70 -2.73%
Close of 7 Aug 2026
Revenue
$4.86M
#3304 by revenue
Earnings
-$2.34M
Loss-making
Shares outstanding
2,056,884
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Arcadia Biosciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.